TD-1473 - Dose A
0176
Phase 1 small_molecule completed
Quick answer
TD-1473 - Dose A for Inflammatory Bowel Diseases is a Phase 1 program (small_molecule) at Theravance Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Inflammatory Bowel Diseases
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed